Gilteritinib
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Gilteritinib, covering 2021-08-16 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) [Phase 1]